Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_assertion type Assertion NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_head.
- NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_provenance.
- NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_assertion evidence source_evidence_literature NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_provenance.
- NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_assertion SIO_000772 11025602 NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_provenance.
- NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_assertion wasDerivedFrom befree-20140225 NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_provenance.
- NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_assertion wasGeneratedBy ECO_0000203 NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_provenance.